Press releases

• EBITDA above prior-year level at 139.9 million euro (plus 5.1 per cent)
• Operational Excellence Programme for the stabilisation of earnings is beginning to take effect
• Sales process for Movianto, Pharmexx and the DocMorris mail-order pharmacy initiated

Company closes financial year 2011 with declining earnings

• Lufthansa Executive Board member to take over from Prof. Jürgen Kluge. Haniel
• Repayment of debt and sustainable value development remains top priority

• Takeover of the remaining 49.9 per cent in Panpharma
• Promising growth opportunities in Brazil due to positive market development and consolidation

• Result to be stabilised in 2012 at the level of the previous year. Operational Excellence Programme will contribute significantly towards this
• Sales process for Movianto, Pharmexx and DocMorris mail-order business initiated
• 2011: Earnings forecast with 578.3 million euro EBITDA before one-off effects achieved

Total dividend of 85 cents proposed for 2011

Joël Saveuse, member of METRO AG’s Management Board and CEO of the Real Group, will leave the company. On Monday evening, Saveuse and the company have mutually agreed that Saveuse will resign from his offices on 31 March 2012.

• One single Management Board headed by Frans Muller
• Business Units are merged and regions reorganised
• Change in top management in Germany